All Episodes

Audio Briefing

/35:24

FILE № 174

FDA Warns of Vision Loss From All GLP1 Drugs

On November 9, 2026 the FDA announced that Ozempic, Wegovy, Mounjaro & Zepbound must have warning labels that these GLP1 drugs can cause sudden, severe, irreversible vision loss or blindness from a condition called …

Listen Now
Audio Briefing

/23:53

FILE № 171

New breast cancer treatment approved by FDA

Leading breast cancer specialist and medical oncologist, Robert Wesolowski, M.D. of the Ohio State University Comprehensive Cancer Center breaks down the latest breakthroughs in breast cancer treatment, including the newly FDA-approved targeted drug REVTORPYK …

Listen Now